NCT06241209 Hemianopsia Rehabilitation After Stroke or Brain Injury
| NCT ID | NCT06241209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Hemianopsia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-01-25 |
| Primary Completion | 2027-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-01-25 with a primary completion date of 2027-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In patients with hemianopsia following stroke or brain injury, we will determine if stimulating the visual field with images from a PowerPoint slide set can increase the visual field.
Eligibility Criteria
Inclusion Criteria: All patients 18 years of age or older with a homonymous hemianopsia or quadrantopsia, who can provide informed consent, and communicate in English. Exclusion Criteria: * The flashing lights from thge automated perimeter and PowerPoint program can potentially trigger photic seizures. Therefore patients with light-induced seizures are excluded.
Frequently Asked Questions
Who can join the NCT06241209 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemianopsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06241209 currently recruiting?
Yes, NCT06241209 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Alberta to inquire about joining.
Where is the NCT06241209 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT06241209 clinical trial?
NCT06241209 is sponsored by University of Alberta. The trial plans to enroll 40 participants.